Skip to main content

Peer Review reports

From: Risk factors of immune checkpoint inhibitor-associated acute kidney injury: evidence from clinical studies and FDA pharmacovigilance database

Original Submission
18 Jun 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
5 Oct 2022 Reviewed Reviewer Report
30 Dec 2022 Reviewed Reviewer Report
1 Feb 2023 Reviewed Reviewer Report - Maurizio Gallieni
8 Mar 2023 Author responded Author comments - Min Feng
Resubmission - Version 3
8 Mar 2023 Submitted Manuscript version 3
18 Mar 2023 Reviewed Reviewer Report - Maurizio Gallieni
20 Mar 2023 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
16 Apr 2023 Editorially accepted
22 Apr 2023 Article published 10.1186/s12882-023-03171-9

You can find further information about peer review here.

Back to article page